Key points are not available for this paper at this time.
Among participants with obesity and knee osteoarthritis with moderate-to-severe pain, treatment with once-weekly injectable semaglutide resulted in significantly greater reductions in body weight and pain related to knee osteoarthritis than placebo. (Funded by Novo Nordisk; STEP 9 ClinicalTrials.gov number, NCT05064735.).
Building similarity graph...
Analyzing shared references across papers
Loading...
Bliddal et al. (Wed,) studied this question.
synapsesocial.com/papers/69d6c52cfca0359822aa865b — DOI: https://doi.org/10.1056/nejmoa2403664
Henning Bliddal
University of Copenhagen
Harold Bays
Louisville Metabolic and Atherosclerosis Research Center
Sébastien Czernichow
Inserm
New England Journal of Medicine
Université Paris Cité
Louisville Metabolic and Atherosclerosis Research Center
Building similarity graph...
Analyzing shared references across papers
Loading...